UAE: Driver Fatigue Accidents Drive Demand for Cognitive and Energy Support Supplements

Dubai, United Arab Emirates — 18 March 2026

New data from the UAE Ministry of Interior reveals that 20 traffic accidents in 2025 were directly attributable to driver fatigue and sleepiness. This figure contributes to a broader trend, with 113 such incidents recorded nationwide between 2022 and 2025. While the 2025 figures show a reduction from the 37 accidents reported in 2022, the persistent occurrence underscores a critical public health and safety issue across the Emirates.

Authorities have intensified awareness campaigns, warning motorists about the severe risks associated with tired driving, including increased likelihood of serious violations such as running red lights and sudden lane deviations. These governmental efforts to highlight the dangers of fatigue inadvertently create a significant market opportunity for supplement brand owners and manufacturers focusing on energy, alertness, and cognitive function support.

Consumer demand for safe and effective solutions to combat fatigue is likely to align with these public safety messages. Brands well-positioned to offer science-backed formulations that enhance focus and sustain energy without adverse side effects could capture a growing segment of the UAE market. This includes products containing ingredients such as B vitamins, L-theanine, natural caffeine sources, and nootropics, provided they adhere strictly to local labelling and import regulations.

What this means for United Arab Emirates

UAE brand owners face a clear opportunity to develop or expand product lines targeting energy and cognitive support, capitalising on heightened public awareness of fatigue. Manufacturers should prioritise formulations with clinically supported ingredients to meet discerning consumer needs and facilitate regulatory approval. Procurement leads must secure reliable supply chains for active ingredients such as B vitamins, coenzyme Q10, and botanical extracts known for energy enhancement under F&B regulations. Compliance teams must ensure all marketing claims align with ESMA and MOHAP guidelines, avoiding therapeutic assertions. This strategic focus can differentiate brands in a competitive market, driven by a genuine consumer need for fatigue countermeasures.

The sustained rate of fatigue-related accidents, declining from 37 in 2022 to 20 in 2025, reflects an ongoing challenge despite awareness efforts. This indicates that while messaging is present, effective consumer-accessible solutions remain paramount. For the supplement industry, this translates into a demand for products that can offer sustained energy and mental clarity, potentially reducing the risk of fatigue-induced errors in daily activities, not just driving.

This trend is being actively addressed by UK manufacturing partners including Supplement Factory.